Chemotherapy of experimental endogenous Candida albicans endophthalmitis.
D000666:Amphotericin B / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000188:drug therapy* / Q000517:prevention & control; D005451:Fluorescein Angiography; D007093:Imidazoles / Q000627:therapeutic use; D007275:Injections, Intravenous; D007654:Ketoconazole; D008825:Miconazole / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D010879:Piperazines / Q000627:therapeutic use; D011817:Rabbits; D012173:Retinitis / Q000175:diagnosis / Q000209:etiology; D013997:Time Factors
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; C017501:methylamphotericin B; D008825:Miconazole; D000666:Amphotericin B; D007654:Ketoconazole